+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Does ex vivo vascular resistance reflect viability of non-heart-beating donor livers?

Does ex vivo vascular resistance reflect viability of non-heart-beating donor livers?

Transplantation Proceedings 37(1): 338-339

Aims. The use of non-heart-beating (NHB) donor livers is limited by a higher risk for primary nonfunction and the absence of methods to measure this risk. This study was designed to determine whether ex vivo vascular resistance of livers correlates with the length of warm ischemia (WI), and, thus, with viability of NHB livers.Methods. Porcine livers were recovered after 0, 45, or 90 minutes WI. Livers were flushed by gravity and cold stored for 3 hours.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 011973821

Download citation: RISBibTeXText

PMID: 15808636

DOI: 10.1016/j.transproceed.2004.11.065

Related references

Donor lazaroids pretreatment improved viability of livers harvested from non-heart beating rats. Gastroenterology 108(4 Suppl. ): A1252, 1995

Donor lazaroid pretreatment improves viability of livers harvested from non-heart-beating rats. American Journal of Surgery 171(1): 113, 1996

Hepatic xanthine levels as viability predictor of livers procured from non-heart-beating donor pigs. Transplantation 71(9): 1232-1237, 2001

Hepatic Xanthine Levels As Viability Predictor Of Livers Procured From Non-Heart-Beating Donor Pigs1. Transplantation 71(9): 1232-1237, 2001

Metabolic and haemodynamic assessment during normothermic extracorporeal perfusion of heart-beating and non-heart-beating-donor livers. Journal of Hepatology 40(Suppl 1): 46, 2004

Assessment of bile produced during normothermic extreacorporeal perfsuion by heart-beating and non-heart-beating-donor livers Proton magnetic resonance spectroscopic study. Journal of Hepatology 40(Suppl 1): 46, 2004

The use of marginal heart beating donor livers for transplantation in the United kingdom. Transplantation 84(1): 70-74, 2007

Non-heart-beating donor porcine livers: the adverse effect of cooling. Liver Transplantation 11(1): 35-38, 2005

Extended preservation of non-heart-beating donor livers with normothermic machine perfusion. British Journal of Surgery 89(5): 609-616, 2002

Viability testing in the non-heart-beating donor. Transplantation Proceedings 32(1): 179-181, 2000

Loss of hepatocyte viability during warm ischemia causes graft failure of livers from non-heart beating donors. Hepatology 30(4 Part 2): 229A, 1999

Preservation of livers from non-heart-beating donors: modulation of cAMP signal and organ viability by glucagon. TransplantationProceedings31(1-2):1068, 1999

Meloxicam, a COX-2 inhibitor, ameliorates ischemia/reperfusion injury in non-heart-beating donor livers. European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes 47(3): 109-117, 2011

Hypothermic machine perfusion preservation of non-heart-beating donor livers in a rat transplantation model. Hepatology 36(4 Part 2): 199A, 2002

Donor categories: heart-beating, non-heart-beating and living donors; evolution within the last 10 years in UZ Leuven and Collaborative Donor Hospitals. Acta Chirurgica Belgica 108(1): 35-38, 2008